Covetrus, Inc.
CVET · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/29/2018 | |
|---|---|---|---|---|
| Market Cap | $2,736 | $3,391 | $1,412 | $4,560 |
| - Cash | $183 | $290 | $130 | $23 |
| + Debt | $1,046 | $1,069 | $1,187 | $24 |
| Enterprise Value | $3,599 | $4,170 | $2,469 | $4,561 |
| Revenue | $4,575 | $4,339 | $3,976 | $3,778 |
| % Growth | 5.4% | 9.1% | 5.2% | – |
| Gross Profit | $858 | $798 | $749 | $684 |
| % Margin | 18.8% | 18.4% | 18.8% | 18.1% |
| EBITDA | $179 | $213 | -$794 | $202 |
| % Margin | 3.9% | 4.9% | -20% | 5.3% |
| Net Income | -$86 | -$19 | -$1,019 | $101 |
| % Margin | -1.9% | -0.4% | -25.6% | 2.7% |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 |
| % Growth | -293.7% | 98.3% | -1,146.2% | – |
| Operating Cash Flow | $102 | $53 | $103 | $158 |
| Capital Expenditures | -$60 | -$58 | -$39 | -$22 |
| Free Cash Flow | $42 | -$5 | $64 | $136 |